A phase II randomized study to compare skin late toxicities of concomitant letrozole-radiotherapy and radiotherapy followed by letrozole as adjuvant therapy for postmenopausal women with receptor (ER and/or PgR) positive tumors

Trial Profile

A phase II randomized study to compare skin late toxicities of concomitant letrozole-radiotherapy and radiotherapy followed by letrozole as adjuvant therapy for postmenopausal women with receptor (ER and/or PgR) positive tumors

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Dec 2015

At a glance

  • Drugs Letrozole (Primary)
  • Indications Breast cancer; Early breast cancer
  • Focus Adverse reactions
  • Acronyms CO-HO-RT
  • Most Recent Events

    • 17 Dec 2015 Results published in the Annals of Oncology
    • 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
    • 05 Feb 2010 Results published in Lancet Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top